Comprehensive characterization of claudin-low breast tumors reflects the impact of the cell-of-origin on cancer evolution - Archive ouverte HAL Access content directly
Journal Articles Nature Communications Year : 2020

Comprehensive characterization of claudin-low breast tumors reflects the impact of the cell-of-origin on cancer evolution

(1, 2, 3) , (1, 2) , (3) , (3) , (3) , (3) , (3) , (4) , (1, 2) , (1, 2) , (1, 2) , (1, 2) , (1, 2, 5)
1
2
3
4
5
Frédéric Hollande

Abstract

Claudin-low breast cancers are aggressive tumors defined by the low expression of key components of cellular junctions, associated with mesenchymal and stemness features. Although they are generally considered as the most primitive breast malignancies, their histogenesis remains elusive. Here we show that this molecular subtype of breast cancers exhibits a significant diversity, comprising three main subgroups that emerge from unique evolutionary processes. Genetic, gene methylation and gene expression analyses reveal that two of the subgroups relate, respectively, to luminal breast cancers and basal-like breast cancers through the activation of an EMT process over the course of tumor progression. The third subgroup is closely related to normal human mammary stem cells. This unique subgroup of breast cancers shows a paucity of genomic aberrations and a low frequency of TP53 mutations, supporting the emerging notion that the intrinsic properties of the cell-of-origin constitute a major determinant of the genetic history of tumorigenesis.
Fichier principal
Vignette du fichier
s41467-020-17249-7.pdf (3.08 Mo) Télécharger le fichier
Origin : Publication funded by an institution
Loading...

Dates and versions

inserm-02908015 , version 1 (28-07-2020)

Identifiers

Cite

Roxane M Pommier, Amelien Sanlaville, Laurie Tonon, Janice Kielbassa, Emilie Thomas, et al.. Comprehensive characterization of claudin-low breast tumors reflects the impact of the cell-of-origin on cancer evolution. Nature Communications, 2020, 11 (1), pp.3431. ⟨10.1038/s41467-020-17249-7⟩. ⟨inserm-02908015⟩
71 View
40 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More